| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |